Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in the field of human aging and longevity. With a commitment to developing therapeutics that aim to extend both lifespan and healthspan, Juvenescence has raised significant funding to create a comprehensive ecosystem targeting aging and age-related diseases. The company collaborates with leading scientists and research institutions to in-license compounds and form joint ventures, leveraging recent scientific advancements to produce evidence-based therapies. By addressing the biological causes of aging, Juvenescence aims to develop medical solutions that promote healthy aging, metabolic health, and brain health. Their efforts are positioned to have substantial implications across various sectors, including healthcare and insurance, as they seek to improve the quality of life for an aging population.
BHB Therapeutics is developing novel approaches to induce a state of ketosis, which may have protective effects against age-related disease.
Napa Therapeutics
Venture Round in 2018
Napa Therapeutics is a biotechnology company focused on a novel target linked to one of the fundamental processes of aging. A privately held British Virgin Islands company with an office in the Isle of Man, Napa is developing small molecule drugs to address this target.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.